Zeotech Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Zeotech heeft een totaal eigen vermogen van A$11.5M en een totale schuld van A$0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk A$12.8M en A$1.3M.

Belangrijke informatie

Verhouding schuld/eigen vermogen

AU$0

Schuld

Rente dekkingsratio	n/a
Contant	AU$2.27m
Aandelen	AU$11.54m
Totaal verplichtingen	AU$1.30m
Totaal activa	AU$12.84m

Recente financiële gezondheidsupdates

Recent updates

Here's Why We're Not Too Worried About Zeotech's (ASX:ZEO) Cash Burn Situation

Aug 29

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

May 07

Is Zeotech (ASX:ZEO) In A Good Position To Deliver On Growth Plans?

Jan 20

Increases to CEO Compensation Might Be Put On Hold For Now at Zeotech Limited (ASX:ZEO)

Nov 21

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Mar 22

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Oct 27

We Think Zeotech (ASX:ZEO) Can Afford To Drive Business Growth

Apr 19

Trade Alert: Anthony Sheridan At Zeotech Limited (ASX:ZEO), Has Just Spent AU$780k Buying 8.8% More Shares

Feb 18

Here's What Zeotech Limited's (ASX:ZEO) Shareholder Ownership Structure Looks Like

Jan 25

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( A$2.3M ) ZEO } overtreffen de korte termijn passiva ( A$1.1M ).

Langlopende schulden: De kortetermijnactiva ZEO ( A$2.3M ) overtreffen de langetermijnschulden ( A$248.2K ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: ZEO is schuldenvrij.

Schuld verminderen: ZEO had 5 jaar geleden geen schulden.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: ZEO heeft minder dan een jaar aan cash runway op basis van de huidige vrije kasstroom.

Voorspelling contante baan: ZEO heeft minder dan een jaar aan kasmiddelen als de vrije kasstroom blijft dalen met historische percentages van 19 % per jaar.

Zeotech Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Here's Why We're Not Too Worried About Zeotech's (ASX:ZEO) Cash Burn Situation

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Is Zeotech (ASX:ZEO) In A Good Position To Deliver On Growth Plans?

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Zeotech Limited to Be Deleted from Other OTC

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Recent updates

Zeotech Limited, Annual General Meeting, Nov 22, 2024

Full year 2024 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2023)

Here's Why We're Not Too Worried About Zeotech's (ASX:ZEO) Cash Burn Situation

Zeotech Limited Appoints Scott Burkhart as Chief Operating Officer

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

MD & Director exercised options and sold AU$232k worth of stock

First half 2024 earnings released: AU$0.002 loss per share (vs AU$0 in 1H 2023)

New major risk - Financial position

New major risk - Share price stability

Is Zeotech (ASX:ZEO) In A Good Position To Deliver On Growth Plans?

Insider recently sold AU$82k worth of stock

New minor risk - Share price stability

Zeotech Limited Announces CEO Changes, Anticipates to Occur from 1 November 2023

Zeotech Limited, Annual General Meeting, Nov 23, 2023

Full year 2023 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2022)

New minor risk - Financial data availability

MD, COO & Director recently sold AU$135k worth of stock

First half 2023 earnings released: EPS: AU$0 (vs AU$0.001 loss in 1H 2022)

Zeotech Limited Appoints Alister Morrison as Chief Executive Officer, Effective 13 March 2023

MD, COO & Director exercised options to buy AU$490k worth of stock.

Zeotech Limited Announces Successful Completion of Pilot Program Accelerates Technology Development

Increases to CEO Compensation Might Be Put On Hold For Now at Zeotech Limited (ASX:ZEO)

No independent directors

Zeotech Limited, Annual General Meeting, Nov 28, 2022

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2021)

Zeotech Limited, Annual General Meeting, Aug 31, 2022

Zeotech Limited Achieves Successful Continuous Closed- Loop Circuit, Utilising Lithium Process By-Product Feedstock (Leached Spodumene) to Produce Pure Linde Type A Manufactured Zeolite

No independent directors

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Zeotech Limited to Be Deleted from Other OTC

Zeotech Limited Announces Pilot Program Update

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Full year 2021 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2020)

Zeotech Limited announced that it expects to receive AUD 3.7005 million in funding

We Think Zeotech (ASX:ZEO) Can Afford To Drive Business Growth

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2020)

Trade Alert: Anthony Sheridan At Zeotech Limited (ASX:ZEO), Has Just Spent AU$780k Buying 8.8% More Shares

Zeotech Limited Pilot Plant Program Commences

Zeotech Limited Executes Research Agreement with UQ to Evaluate Carbon Capture Using Synthetic Zeolites

Here's What Zeotech Limited's (ASX:ZEO) Shareholder Ownership Structure Looks Like

Zeotech Limited Announces resignation of John Goody as Non-Executive Director

Metalsearch Limited Announces Participating in Agronomic Trials to Evaluate the Performance of Synthetic Zeolites Across A Range of Agricultural Applications

Full year earnings released

Metalsearch Limited announced that it has received AUD 1.6575 million in funding

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse van de cashflow

Ontdek gezonde bedrijven